Oct 3
|
Apyx (APYX) Upgraded to Buy: Here's What You Should Know
|
Jul 25
|
At US$1.39, Is It Time To Put Apyx Medical Corporation (NASDAQ:APYX) On Your Watch List?
|
Jul 25
|
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
|
Jun 26
|
Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health
|
May 13
|
Apyx Medical Corporation (NASDAQ:APYX) Q1 2024 Earnings Call Transcript
|
May 12
|
Analysts Have Been Trimming Their Apyx Medical Corporation (NASDAQ:APYX) Price Target After Its Latest Report
|
May 11
|
Apyx Medical First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
May 9
|
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
|
May 9
|
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
|
May 9
|
Apyx Medical Corporation Announces Board Leadership Transition
|
Apr 25
|
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
|
Apr 11
|
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
|
Mar 26
|
Downgrade: Here's How Analysts See Apyx Medical Corporation (NASDAQ:APYX) Performing In The Near Term
|
Mar 23
|
Apyx Medical Corporation (NASDAQ:APYX) Just Reported And Analysts Have Been Cutting Their Estimates
|
Mar 22
|
Apyx Medical Corporation (NASDAQ:APYX) Q4 2023 Earnings Call Transcript
|
Mar 22
|
Further weakness as Apyx Medical (NASDAQ:APYX) drops 22% this week, taking three-year losses to 87%
|
Mar 22
|
Q4 2023 Apyx Medical Corp Earnings Call
|
Mar 21
|
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
|
Mar 21
|
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
|
Mar 4
|
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
|